Adverse events following immunization with typhoid conjugate vaccine in an outbreak setting in Hyderabad, Pakistan
Open Access
- 20 March 2020
- Vol. 38 (19), 3518-3523
- https://doi.org/10.1016/j.vaccine.2020.03.028
Abstract
No abstract availableKeywords
Funding Information
- Bill & Melinda Gates Foundation
This publication has 17 references indexed in Scilit:
- Phase 3 Efficacy Analysis of a Typhoid Conjugate Vaccine Trial in NepalNew England Journal of Medicine, 2019
- A Systematic Review of Typhoid Fever Occurrence in AfricaClinical Infectious Diseases, 2019
- Ceftriaxone-resistantSalmonellaTyphi Outbreak in Hyderabad City of Sindh, Pakistan: High Time for the Introduction of Typhoid Conjugate VaccineClinical Infectious Diseases, 2019
- Extensively Drug-Resistant Typhoid — Are Conjugate Vaccines Arriving Just in Time?New England Journal of Medicine, 2018
- A Retrospective Study of Laboratory-Based Enteric Fever Surveillance, Pakistan, 2012–2014The Journal of Infectious Diseases, 2018
- Safety and immunogenicity of a Vi-DT typhoid conjugate vaccine: Phase I trial in Healthy Filipino adults and childrenVaccine, 2018
- Emergence of an Extensively Drug-Resistant Salmonella enterica Serovar Typhi Clone Harboring a Promiscuous Plasmid Encoding Resistance to Fluoroquinolones and Third-Generation CephalosporinsmBio, 2018
- Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trialThe Lancet, 2017
- Surveillance of adverse events following immunization in China: Past, present, and futureVaccine, 2015
- Typhoid Fever and Its Association with Environmental Factors in the Dhaka Metropolitan Area of Bangladesh: A Spatial and Time-Series ApproachPLoS Neglected Tropical Diseases, 2013